A new study links telomere length and polygenic risk scores to IPF development, highlighting genetic drivers beyond rare variants.
David Zhang, MD
Advertisement
David Zhang, MD, is a pulmonary disease medicine specialist at Columbia University Irving Medical Center.
Articles by David Zhang, MD
A new study links telomere length genetics to IPF risk, showing how rare variants and polygenic scores may guide future screening and precision care.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Flatiron’s AI-Driven Telescope Makes Data Access More User-Friendly
2
Legend Biotech’s CAR T-cell Therapy Shows Early Promise in SCLC, Other Tumors
3
Social Factors May Match, Outpace Genetic Risk in Disease Prediction
4
Long-Term, Consistent Resistance Training Linked to Substantially Lower Type 2 Diabetes Risk
5